Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-07-29
2008-07-29
Seaman, Margaret D. (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
11538762
ABSTRACT:
Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of 5-lipoxygenase-activating protein (FLAP). Also described herein are methods of using such FLAP modulators, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions or diseases.
REFERENCES:
patent: 5081138 (1992-01-01), Gillard et al.
patent: 2004/0198800 (2004-10-01), Allan et al.
patent: 1749829 (2006-03-01), None
Miller et al., “Identification and isolation of a membrane protein necessary for leukotrine production,” Nature 343:278-281 (1990) Abstract only.
PCT/US06/39421 Search Report dated Jan. 18, 2008.
Evans Jillian F.
Hutchinson John H.
Moran Mark
Prasit Petpiboon Peppi
Stock Nicholas Simon
Amira Pharmaceuticals, Inc.
Rahmani Niloofar
Seaman Margaret D.
Wilson Sonsini Goodrich & Rosati
LandOfFree
5-lipoxygenase-activating protein (FLAP) inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5-lipoxygenase-activating protein (FLAP) inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-lipoxygenase-activating protein (FLAP) inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3911474